TABLE 3.

FA composition of total lipids from rat retina tissue following supplemented diets

Percent of Total FAs	Control	PL-EPA	PL-DHA	TG-EPA	TG-DHA
14:0	0.16 ± 0.03	0.07 ± 0.01a	0.10 ± 0.05	0.16 ± 0.05	0.07 ± 0.02b,c
15:0	0.08 ± 0.02	0.05 ± 0.01a	0.07 ± 0.02	0.08 ± 0.02	0.05 ± 0.01b,c
dma 16:0	0.88 ± 0.08	0.85 ± 0.08	0.86 ± 0.09	0.86 ± 0.1	0.83 ± 0.04
16:0	20.18 ± 0.58	16.47 ± 0.53d	17.78 ± 2.01a	18.65 ± 2.02	16.86 ± 0.86a
16:1n-9	0.21 ± 0.02	0.15 0.01b	0.17 ± 0.03	0.19 ± 0.03	0.15 ± 0.01d
16:1n-7	0.37 ± 0.06	0.30 ± 0.05	0.36 ± 0.07	0.40 ± 0.12	0.26 ± 0.02b,e,f
17:0	0.15 ± 0.01	0.14 ± 0.01	0.17 ± 0.02	0.15 ± 0.01	0.13 ± 0.01a,g
dma 18:0	2.75 ± 0.08	2.83 ± 0.12	2.72 ± 0.11	2.76 ± 0.14	2.83 ± 0.11
dma 18:1n-9	0.41 ± 0.04	0.37 ± 0.04	0.37 ± 0.03	0.38 ± 0.03	0.36 ± 0.02
dma 18:1n-7	0.21 ± 0.03	0.22 ± 0.05	0.21 ± 0.04	0.19 ± 0.03	0.17 ± 0.02a,h
18:0	25.35 ± 0.56	24.80 ± 0.45c	24.94 ± 0.91	26.06 ± 0.86	25.46 ± 0.65
18:1t	0.05 ± 0.01	0.04 ± 0.01	0.06 ± 0.01	0.05 ± 0.01	0.04 ± 0.0b,c,i
18:1n-9	9.16 ± 0.29	8.55 ± 0.46	8.48 ± 0.44a	9.05 ± 0.47	8.43 ± 0.35a
18:1n-7	2.48 ± 0.16	2.27 ± 0.18	2.23 ± 0.17	2.21 ± 0.15	1.90 ± 0.12d,h
18:2n-6	0.76 ± 0.11	0.87 ± 0.09	0.74 ± 0.1	0.92 ± 0.12	0.8 ± 0.06
20:0	0.11 ± 0.02	0.09 ± 0.02	0.09 ± 0.02	0.14 ± 0.02e,h,j	0.09 ± 0.01a
20:1n-9	0.17 ± 0.01	0.13 ± 0.0a	0.14 ± 0.02a	0.16 ± 0.03	0.17 ± 0.02
20:1n-7	0.04 ± 0.0	0.03 ± 0.01f	0.04 ± 0.02	0.06 ± 0.02	0.05 ± 0.02
20:2n-6	0.09 ± 0.01	0.09 ± 0.01	0.09 ± 0.01	0.09 ± 0.01	0.09 ± 0.01
20:3n-9	0.05 ± 0.01	0.05 ± 0.03	0.06 ± 0.04	0.08 ± 0.04	0.04 ± 0.01
20:3n-6	0.13 ± 0.01	0.17 ± 0.0d,g	0.13 ± 0.01	0.15 ± 0.02	0.15 ± 0.01
20:4n-6	8.72 ± 0.31	8.10 ± 0.49	8.33 ± 0.23	7.86 ± 0.52b	7.85 ± 0.31b
20:5n-3	0.07 ± 0.02	0.42 ± 0.05d,i	0.27 ± 0.04	0.35 ± 0.04b	0.33 ± 0.05a
24:0	0.04 ± 0.01	0.05 ± 0.02	0.06 ± 0.01	0.09 ± 0.02b,k	0.04 ± 0.01
22:4n-6	1.24 ± 0.06	0.91 ± 0.06b	1.01 ± 0.08	0.90 ± 0.08d	0.90 ± 0.05d
22:5n-6	0.59 ± 0.1	0.10 ± 0.01d,l	0.14 ± 0.01a	0.13 ± 0.02b	0.15 ± 0.02
22:5n-3	0.34 ± 0.03	0.89 ± 0.06d,e	0.62 ± 0.05	0.88 ± 0.04d,e	0.67 ± 0.07
22:6n-3	25.09 ± 0.5	30.87 ± 1.28d	29.77 ± 1.65a	27.02 ± 1.61	31.15 ± 1.18c,d
Total of n-3 PUFAs	25.51 ± 0.5	32.19 ± 1.32d	30.67 ± 1.64a	28.25 ± 1.58	32.15 ± 1.11d
Total n-6 PUFAs	11.55 ± 0.39	10.27 ± 0.63a	10.44 ± 0.35	10.05 ± 0.60b	9.95 ± 0.40d
Total PUFAs	37.12 ± 0.60	42.51 ± 0.90d,f,l	41.17 ± 1.53a	38.38 ± 1.72	42.15 ± 0.89b
Total SFAs	46.11 ± 0.61	41.71 ± 0.71d,f	43.21 ± 1.43a	45.33 ± 1.30	42.70 ± 0.58a
Total MUFAs	12.51 ± 0.44	11.50 ± 0.68	11.47 ± 0.62	12.11 ± 0.67	10.97 ± 0.45d
n-6/n-3 PUFAs	0.45 ± 0.01	0.32 ± 0.03d	0.34 ± 0.03	0.36 ± 0.03	0.31 ± 0.02d

Values are mean ± SD (n = 8 rats per group). Probabilities were determined by Kruskal Wallis test followed by the Dunn’s post hoc test. DMA, dimethyl acetal; SFA, saturated FA.

^aP < 0.05 when the supplemented groups were compared with the control group.

^bP < 0.01 when the supplemented groups were compared with the control group.

^cP < 0.05 when the supplemented groups were compared with the TG-EPA group.

^dP < 0.001 when the supplemented groups were compared with the control group.

^eP < 0.05 when the supplemented groups were compared with the PL-DHA group.

^fP < 0.01 when the supplemented groups were compared with the TG-EPA group.

^gP < 0.001 when the supplemented groups were compared with the PL-DHA group.

^hP < 0.05 when the supplemented groups were compared with the PL-EPA group.

ⁱP < 0.01 when the supplemented groups were compared with the PL-DHA group.

^jP < 0.001 when the supplemented groups were compared with the TG-DHA group.

^kP < 0.01 when the supplemented groups were compared with the TG-DHA group.

^lP < 0.05 when the supplemented groups were compared with the TG-DHA group.